DiscoverBlogResourcesAbout
Company
  • Blog
  • Resources
  • About
  • Brand Assets
  • Careers
Ecosystem
  • Shop DeSci
  • Bio Protocol
  • Biofy
  • BIOS
  • DeSci Codes

By subscribing you agree to our Privacy Policy and Terms of Service

© 2026 Molecule. All rights reserved.

Privacy PolicyTerms of Service
Back to Blog Overview

Molecule Partners with CryoDAO to Expand Onchain Intellectual Property and Advance Cryopreservation Research

Molecule, a leader in decentralized science (DeSci) and a pioneer in tokenized intellectual property (IP), is thrilled to announce its strategic partnership with CryoDAO.

Jul 15, 2024
•
4 min read
•Jillian Casalini
Molecule Partners with CryoDAO to Expand Onchain Intellectual Property and Advance Cryopreservation Research

Molecule, a leader in decentralized science (DeSci) and a pioneer in tokenized intellectual property (IP), is thrilled to announce its strategic partnership with CryoDAO, a decentralized collective dedicated to funding high-impact research to advance cryopreservation techniques. 

Working on the bleeding edge of scientific innovation, CryoDAO’s mandate is to make death optional. We will be working together to further their mission, bringing cryopreservation research projects to the DeSci community utilizing Molecule IP tokens: IP-NFTs and IPTs.  

‍

Powered by Molecule IP Tokens 

Molecule IP tokens transform the management of scientific IP through tokenization:

  • Intellectual Property NFTs (IP-NFTs): IP-NFTs are non-fungible tokens that register scientific IP onchain. IP-NFTs provide a secure, immutable record of scientific IP ownership and rights, enabling easy IP transfer, verification, and management.
  • Intellectual Property Tokens (IPTs): IPTs are fungible tokens that distribute the IP rights associated with a particular IP-NFT, decentralizing its scientific process by enabling globally distributed governance of it and transforming the way scientists engage with their online communities.  

Molecule IP-NFTs and IPTs empower CryoDAO to accelerate the pace of cryopreservation research and funding by bringing scientific IP onchain.  

‍

Combining Biotech Dealflow Expertise

Working closely with the CryoDAO scientific research dealflow team, Molecule’s biotech team will aid in experimental planning, IP strategy, and negotiation, leveraging an existing partnership with Nucleate. 

You can learn more about Molecule’s partnership with Nucleate to source cutting-edge scientific research for IP tokenization from all around the world here. 

Together, CryoDAO and Molecule will build a pipeline of groundbreaking cryopreservation research projects and tokenize them.  

‍

Growing Onchain IP Through Cryopreservation

This collaboration marks an important step towards a more vibrant and innovative DeSci ecosystem, leveraging the strengths of both organizations to make a meaningful impact. To stay up to date on the partnership, follow Molecule on X or sign up for our newsletter. 

About the author

Jillian Casalini

Jillian Casalini

I'm a biotech strategist and marketer with a foundation in traditional pharma and a vision for decentralized innovation. My career began in traditional pharma at Eli Lilly, where I learned how large-scale organizations bring rigor, regulation, and reach to life sciences. I also built a strong foundation in go-to-market strategy—bridging science with storytelling and turning complex research into clear, compelling narratives. That experience now fuels my passion for building at the intersection of biotech and decentralized science (DeSci)—where transparency, open collaboration, and new funding models are reshaping how research gets done.

Follow on XConnect on LinkedIn

Related Posts

Science IP Tokens /acc
Sep 22, 2025
Science IP Tokens /acc
Building the Hypothesis-to-IP Flywheel: BioAgents, ResearchHub & Molecule
Aug 21, 2025
Building the Hypothesis-to-IP Flywheel: BioAgents, ResearchHub & Molecule
One Interface for Onchain Science: Molecule Labs Has Arrived
Jun 10, 2025
One Interface for Onchain Science: Molecule Labs Has Arrived

"We are thrilled to enter into this cool partnership with CryoDAO, which accelerates our vision of tokenizing scientific IP, enabling new sources of capital to fund valuable, underfunded research areas like cryonics. We believe that DeSci has the opportunity to make crypto a force for enabling researchers to work on humanity’s biggest problems and for communities to bring discoveries to life that would never have existed otherwise. We are excited to charge the chilling growth of the CryoDAO community to make cryonics a reality and make taxes the only guarantee in life." Benji Leibowitz, COO at Molecule

“Together with Molecule, CryoDAO will push the boundaries of decentralized science, tokenizing the most important research in the world—research that will save our very lives. By calling on a global community to advance this science, we have an opportunity to change the course of human history forever. This partnership is an important first step.”  Kai Micah Mills, co-founder of CryoDAO.

‍

About Molecule

Molecule is dedicated to advancing scientific research through permissionless funding and the tokenization of intellectual property (IP). By transforming scientific IP into a liquid onchain asset, Molecule aligns the incentives of researchers and funders, fostering a more collaborative and efficient research ecosystem. 

‍

About CryoDAO

CryoDAO envisions a world where organs and tissues preserved in vast biobanks are available to patients on demand, where journeys to distant stars become journeys in slumber, and where even life can be frozen in time. CryoDAO funds research projects that have a high potential to increase the quality and capabilities of cryopreservation.